Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
Is he pricing up his French Chateau?
Well - I am looking at SYME and seeing a
- Bull talking CEO
- Auditors who don’t want to know going forward
- Chairman sells shares on the back of a totally rubbish story of personal IPO costs of more than £1 million
This could easily end in tears but I want in to succeed for Neddy1
Nice one Warren
I have a warehouse with 8 weeks (Sales)worth of stock and I want to raise for funds
I sell 70% to a SYME created stock Company. In a couple of days some of the stock I sold to the SYME stock Company is ordered by Customers - do I then buy it back and re sell it to my Customer ???
I am a little disappointed with the results - thought Revenues would be higher and losses lower. I can’t make the call but would be interested to know capacity utilisation in H1
Or a Cruise Ship
Brooko - that would be sensational news - they need to crack on and get more capacity
I hold a large number of Orph and hopefully looking forward to a sustained growth in the SP
Is there a limit to utilisation / revenue due to the fact that we only have 24 beds and (as they are fully occupied) how can revenue grow any further (except for price rises)??
Mick2 - so you guestimate that that SYME will be in a position (this time next year) to pay a Dividend of 0.25p which would cost them £80 million (post tax) - and you wonder why Rampers get a bad name!!!
Dangerous that you tampers are not prepared to countenance opinions on stocks that differ from your own. You need balance and should fully consider all the risks and warning raised by posters who are weary of SYME and it’s management
Jonesrichard - that was one of the most naive posting ever. So Rolls Royce cannot fund Inventory or other assets without the wonders of SYME - totally ridiculous that it’s FD and Bankers are at a loss without SYME. There is a massive industry dedicated to funding businesses through all kinds of sophisticated instruments - SYME is nothing new
Floating / Selling the Drugs in development could be big (as could the data base info) - in total this could easily hit 50p